デフォルト表紙
市場調査レポート
商品コード
1439582

経カテーテル僧帽弁修復術デバイス - 世界市場の考察、競合情勢、市場予測(2030年)

Transcatheter Mitral Valve Repair Devices - Market Insights, Competitive Landscape, and Market Forecast - 2030

出版日: 受注後更新 | 発行: DelveInsight | ページ情報: 英文 150 Pages | 納期: 2~10営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報(例:国別セグメント)の追加などの対応が可能です。  詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=158.31円
経カテーテル僧帽弁修復術デバイス - 世界市場の考察、競合情勢、市場予測(2030年)
出版日: 受注後更新
発行: DelveInsight
ページ情報: 英文 150 Pages
納期: 2~10営業日
ご注意事項 :
本レポートの納品は、最新情報反映のため受注時に適宜更新しお届けいたします。
更新情報の反映作業にあたり納期もレポート毎に異なりますので、ご検討の際はお問い合わせください。
  • 全表示
  • 概要
  • 図表
  • 目次
概要

世界の経カテーテル僧帽弁修復術デバイスの市場規模は、2023年に11億9,706万米ドル、2030年までに27億5,671万米ドルに達し、2024年~2030年の予測期間にCAGRで14.95%の成長が見込まれます。経カテーテル僧帽弁修復術デバイスの需要は主に、僧帽弁狭窄症、僧帽弁逸脱症、僧帽弁逆流症などの心臓弁疾患の有病率の増加によって後押しされています。さらに、冠動脈疾患、心筋梗塞、うっ血性心不全、狭心症などの心血管疾患の有病率の増加、製品開発における技術革新、製品の発売や承認の増加などが、2024年~2030年の予測期間における経カテーテル僧帽弁修復術デバイス市場の全体的な成長に寄与しています。

経カテーテル僧帽弁修復術デバイスの市場力学

経カテーテル僧帽弁修復術デバイス市場はさまざまな要因によって製品需要が伸びており、主な要因の1つは、僧帽弁狭窄症、僧帽弁逸脱、僧帽弁逆流症などの心臓弁疾患の有病率の増加です。

British Heart Foundation(BHF)は2023年、ライフスタイルの変化、高齢化、人口増加により、2022年に世界中で約5億5,000万人が心臓・循環器疾患を抱えて生活していると報告しました。

さらに、世界保健機関(WHO)(2020)によると、石灰化大動脈弁狭窄症の有病率は全世界で900万人でした。また、John Muir Healthの統計によると、2020年に米国で約150万人が大動脈弁狭窄症に罹患し、このうち約50万人が重度の大動脈弁狭窄症に罹患しています。同じ資料によると、2020年に、米国で大動脈弁狭窄症に罹患している患者のうち約25万人が症候性でした。このように、さまざまな心臓弁疾患を含む心血管疾患の有病率の増加は、経カテーテル僧帽弁修復術デバイスの需要を増加させます。

低侵襲手術に対する患者の選好の高まりも、予測期間の市場成長によい結果をもたらす見込みです。経カテーテル僧帽弁修復術デバイスは、回復時間の短縮、術後の痛みの軽減、入院期間の短縮、創傷合併症の軽減、よりよい創傷プロテーゼなど、低侵襲アプローチにより、従来の手術に対する利点を提供します。

さらに、製品の発売や承認の増加が市場にプラスの影響を与えます。例えば、2019年3月、米国食品医薬品局(FDA)はAbbottが開発したMitraClipを承認しました。このデバイスは、中等度から重度、あるいは重度の僧帽弁逆流を軽減するための心臓弁修復術デバイスとして使用されます。これは低侵襲の医療処置であり、1~3時間で済みます。

したがって、上記の要因が2024年~2030年の予測期間の経カテーテル僧帽弁修復術デバイス市場の成長に寄与します。

しかし、経カテーテル僧帽弁修復術に伴うリスクなどが、2024年~2030年の予測期間の経カテーテル僧帽弁修復術デバイス市場の成長を抑制する可能性があります。

経カテーテル僧帽弁修復術デバイス市場は、COVID-19の蔓延を抑制するために必要な措置としてロックダウン規制が実施されたため、一時的に後退した時期がありました。経カテーテル僧帽弁修復術デバイスの需要は、心臓手術などに向けて病院や診療所に入院する患者数の減少によって妨げられました。さらに、製造や研究開発活動は、厳格なロックダウン規則が課され、資源が不足したために停止しました。しかし、さまざまな活動が再開され、世界のさまざまな地域でワクチンが投与されるようになり、病院における診断や心臓手術を受ける患者の回復に伴い、経カテーテル僧帽弁修復術デバイスの需要が大幅に増加しました。したがって、前述の要因がパンデミック中に経カテーテル僧帽弁修復術デバイスの需要を促進し、予測期間も同じように成長すると推定されます。

経カテーテル僧帽弁修復術デバイス市場のセグメント分析

経カテーテル僧帽弁修復術デバイス市場の製品セグメントでは、生体組織弁カテゴリが2023年に大きな収益シェアを獲得すると予測されています。これは、このセグメントによって提供される利点と、僧帽弁逆流症の有病率の増加によるものです。

当レポートでは、世界の経カテーテル僧帽弁修復術デバイス市場について調査分析し、市場規模と予測、促進要因と課題、企業と製品のプロファイルなどを提供しています。

目次

第1章 経カテーテル僧帽弁修復術デバイス市場レポートのイントロダクション

第2章 経カテーテル僧帽弁修復術デバイス市場のエグゼクティブサマリー

  • 調査範囲
  • 市場の概要
  • 競合の評価

第3章 規制分析

  • 米国
  • 欧州
  • 日本
  • 中国

第4章 経カテーテル僧帽弁修復術デバイス市場の主な要因の分析

  • 経カテーテル僧帽弁修復術デバイス市場の促進要因
    • 心臓弁膜症の有病率の増加
    • 低侵襲手術への関心の高まり
  • 経カテーテル僧帽弁修復術デバイス市場の抑制要因と課題
    • 術後合併症のリスク
  • 経カテーテル僧帽弁修復術デバイス市場の機会
    • パイプラインにおける多数の修復術デバイスのプレゼンス

第5章 経カテーテル僧帽弁修復術デバイス市場のポーターのファイブフォース分析

第6章 経カテーテル僧帽弁修復術デバイス市場レイアウト

  • タイプ別
    • 機械式弁
    • 生体組織(生体)弁
  • 適応症別
    • 僧帽弁閉鎖不全症
    • 僧帽弁狭窄症
    • その他
  • エンドユーザー別
    • 病院、診療所
    • 外来手術センター
  • 地域別
    • 北米
    • 欧州
    • アジア太平洋
    • その他の地域

第7章 経カテーテル僧帽弁修復術デバイス市場の企業と製品のプロファイル

  • Abbott
  • Edwards Lifesciences Corporation.
  • Shockwave Medical, Inc.
  • LivaNova PLC
  • NeoChord, Inc.
  • Coramaze Technologies
  • CryoLife, Inc.
  • Auto Tissue Berlin GmbH.
  • Medtronic
  • Boston Scientific Corporation
  • JenaValve Technology, Inc

第8章 KOLの見解

第9章 プロジェクトのアプローチ

第10章 DelveInsightについて

第11章 免責事項とお問い合わせ

図表

List of Tables

  • Table 1: Competitive Analysis
  • Table 2: COVID-19 Impact Analysis
  • Table 3: Transcatheter mitral valve repair Devices Market in Global (2021-2030)
  • Table 4: Transcatheter mitral valve repair Devices Market in Global by Type (2021-2030)
  • Table 5: Transcatheter mitral valve repair Devices Market in Global by Indication (2021-2030)
  • Table 6: Transcatheter mitral valve repair Devices Market in Global by End-User (2021-2030)
  • Table 7: Transcatheter mitral valve repair Devices Market in Global by Geography (2021-2030)
  • Table 8: Transcatheter mitral valve repair Devices Market in North America (2021-2030)
  • Table 9: Transcatheter mitral valve repair Devices Market in North America by Country (2021-2030)
  • Table 10: Transcatheter mitral valve repair Devices Market in the US (2021-2030)
  • Table 11: Transcatheter mitral valve repair Devices Market in Canada (2021-2030)
  • Table 12: Transcatheter mitral valve repair Devices Market in Mexico (2021-2030)
  • Table 13: Transcatheter mitral valve repair Devices Market in Europe (2021-2030)
  • Table 14: Transcatheter mitral valve repair Devices Market in Europe by Country (2021-2030)
  • Table 15: Transcatheter mitral valve repair Devices Market in France (2021-2030)
  • Table 16: Transcatheter mitral valve repair Devices Market in Germany (2021-2030)
  • Table 17: Transcatheter mitral valve repair Devices Market in the United Kingdom (2021-2030)
  • Table 18: Transcatheter mitral valve repair Devices Market in Italy (2021-2030)
  • Table 19: Transcatheter mitral valve repair Devices Market in Spain (2021-2030)
  • Table 20: Transcatheter mitral valve repair Devices Market in the Rest of Europe (2021-2030)
  • Table 21: Transcatheter mitral valve repair Devices Market in Asia-Pacific (2021-2030)
  • Table 22: Transcatheter mitral valve repair Devices Market in Asia-Pacific by Country (2021-2030)
  • Table 23: Transcatheter mitral valve repair Devices Market in China (2021-2030)
  • Table 24: Transcatheter mitral valve repair Devices Market in Japan (2021-2030)
  • Table 25: Transcatheter mitral valve repair Devices Market in India (2021-2030)
  • Table 26: Transcatheter mitral valve repair Devices Market in Australia (2021-2030)
  • Table 27: Transcatheter mitral valve repair Devices Market in South Korea (2021-2030)
  • Table 28: Transcatheter mitral valve repair Devices Market in Rest of Asia-Pacific (2021-2030)
  • Table 29: Transcatheter mitral valve repair Devices Market in the Rest of the World (2021-2030)
  • Table 30: Transcatheter mitral valve repair Devices Market in RoW by Region (2021-2030)
  • Table 31: Transcatheter mitral valve repair Devices Market in the Middle East (2021-2030)
  • Table 32: Transcatheter mitral valve repair Devices Market in Africa (2021-2030)
  • Table 33: Transcatheter mitral valve repair Devices Market in South America (2021-2030)

List of Figures

  • Figure 1: Competitive Analysis
  • Figure 2: COVID-19 Impact Analysis
  • Figure 3: Transcatheter mitral valve repair Devices Market in Global (2021-2030)
  • Figure 4: Transcatheter mitral valve repair Devices Market in Global by Type (2021-2030)
  • Figure 5: Transcatheter mitral valve repair Devices Market in Global by Indication (2021-2030)
  • Figure 6: Transcatheter mitral valve repair Devices Market in Global by End-User (2021-2030)
  • Figure 7: Transcatheter mitral valve repair Devices Market in Global by Geography (2021-2030)
  • Figure 8: Transcatheter mitral valve repair Devices Market in North America (2021-2030)
  • Figure 9: Transcatheter mitral valve repair Devices Market in North America by Country (2021-2030)
  • Figure 10: Transcatheter mitral valve repair Devices Market in the US (2021-2030)
  • Figure 11: Transcatheter mitral valve repair Devices Market in Canada (2021-2030)
  • Figure 12: Transcatheter mitral valve repair Devices Market in Mexico (2021-2030)
  • Figure 13: Transcatheter mitral valve repair Devices Market in Europe (2021-2030)
  • Figure 14: Transcatheter mitral valve repair Devices Market in Europe by Country (2021-2030)
  • Figure 15: Transcatheter mitral valve repair Devices Market in France (2021-2030)
  • Figure 16: Transcatheter mitral valve repair Devices Market in Germany (2021-2030)
  • Figure 17: Transcatheter mitral valve repair Devices Market in the United Kingdom (2021-2030)
  • Figure 18: Transcatheter mitral valve repair Devices Market in Italy (2021-2030)
  • Figure 19: Transcatheter mitral valve repair Devices Market in Spain (2021-2030)
  • Figure 20: Transcatheter mitral valve repair Devices Market in the Rest of Europe (2021-2030)
  • Figure 21: Transcatheter mitral valve repair Devices Market in Asia-Pacific (2021-2030)
  • Figure 22: Transcatheter mitral valve repair Devices Market in Asia-Pacific by Country (2021-2030)
  • Figure 23: Transcatheter mitral valve repair Devices Market in China (2021-2030)
  • Figure 24: Transcatheter mitral valve repair Devices Market in Japan (2021-2030)
  • Figure 25: Transcatheter mitral valve repair Devices Market in India (2021-2030)
  • Figure 26: Transcatheter mitral valve repair Devices Market in Australia (2021-2030)
  • Figure 27: Transcatheter mitral valve repair Devices Market in South Korea (2021-2030)
  • Figure 28: Transcatheter mitral valve repair Devices Market in Rest of Asia-Pacific (2021-2030)
  • Figure 29: Transcatheter mitral valve repair Devices Market in the Rest of the World (2021-2030)
  • Figure 30: Transcatheter mitral valve repair Devices Market in RoW by Region (2021-2030)
  • Figure 31: Transcatheter mitral valve repair Devices Market in the Middle East (2021-2030)
  • Figure 32: Transcatheter mitral valve repair Devices Market in Africa (2021-2030)
  • Figure 33: Transcatheter mitral valve repair Devices Market in South America (2021-2030)
  • Figure 34: Market Drivers
  • Figure 35: Market Barriers
  • Figure 36: Marker Opportunities
  • Figure 37: PORTER'S Five Force Analysis
目次
Product Code: DIMDCL0411

Transcatheter Mitral Valve Repair Devices Market By Product (Mechanical Valve And Bioprosthetic Tissue Valve), Indication (Mitral Valve Regurgitation, Mitral Valve Stenosis, And Others), End-User (Hospitals & Clinics, Ambulatory Surgical Centers, And Others), and geography is expected to grow at a steady CAGR forecast till 2030 owing to the increasing prevalence of heart valve diseases and the growing demand for minimally invasive surgeries across the globe

The global transcatheter mitral valve repair devices market was valued at USD 1,197.06 million in 2023, growing at a CAGR of 14.95% during the forecast period from 2024 to 2030 to reach USD 2,756.71 million by 2030. The demand for transcatheter mitral valve repair devices is primarily being boosted by the increasing prevalence of heart valve diseases such as mitral valve stenosis, mitral valve prolapse, mitral valve regurgitation, and others. Further, the increasing prevalence of coronary artery disease, myocardial infarction, congestive heart failures, angina pectoris, and other cardiovascular diseases, along with innovation in product development and rising product launches and approvals are thereby contributing to the overall growth of the transcatheter mitral valve repair devices market during the forecast period from 2024-2030.

Transcatheter Mitral Valve Repair Devices Market Dynamics:

The transcatheter mitral valve repair devices market is witnessing a growth in product demand owing to various factors, one of the key factors being the increase in the prevalence of heart valve diseases such as mitral valve stenosis, mitral valve prolapse, mitral valve regurgitation, and others.

According to the British Heart Foundation (BHF), it was reported in 2023, that around 550 million people in 2022 were living with heart and circulatory diseases across the world owing to changing lifestyles, aging, and a growing population.

Further, according to the World Health Organization (WHO) 2020, the prevalence of calcific aortic valve stenosis was 9 million across the world. Also, as per the John Muir Health statistics, in the year 2020, about 1.5 million people in the United States suffered from aortic stenosis, and about 500,000 people within this group of patients suffered from severe aortic stenosis. As per the same source in 2020, about 250,000 patients suffering from aortic stenosis were symptomatic in the United States. Thus, the increasing prevalence of cardiovascular diseases including various heart valve diseases will increase the demand for transcatheter mitral valve repair devices.

The increasing patient preference for minimally invasive surgeries is also likely to bode well for the market growth during the forecast period. Transcatheter mitral valve repair devices offer advantages over conventional surgeries owing to their minimally invasive approach, such as shorter recovery time, less post-operational pain, less stay at the hospital, fewer wound complications, and better wound prosthesis.

Further, the rising product launches and approvals will create a positive impact on the market. For instance, in March 2019, the US Food and Drug Administration (FDA) approved MitraClip, developed by Abbott. The device is used as a heart valve repair device that was intended to reduce moderate-to-severe or even severe mitral regurgitation. It is a minimally invasive medical procedure and takes only 1-3 hours.

Therefore, the above-mentioned factors are contributing to the growth of the Transcatheter mitral valve repair devices market during the forecast period from 2024-2030.

However, risks associated with transcatheter mitral valve repair procedures and others may restrict the transcatheter mitral valve repair devices' market growth during the forecast period from 2024-2030.

The transcatheter mitral valve repair devices market experienced a period of a temporary setback as lockdown restrictions were enforced as a necessary step to curb the spread of COVID-19. The demand for transcatheter mitral valve repair devices was disrupted owing to the decline in the number of patients in hospitals & clinics for surgeries such as cardiac surgery. Moreover, manufacturing and research & development activities were halted owing to the imposition of strict lockdown rules and due to a lack of resources. However, with the resumption of various activities and with the administration of vaccines across different regions of the world, the demand for transcatheter mitral valve repair devices increased significantly with the resumption of patients in hospitals for diagnosis and heart surgeries. Henceforth, the aforementioned factors propelled the demand for transcatheter mitral valve repair devices during the pandemic and are estimated to grow similarly during the forecast period.

Transcatheter Mitral Valve Repair Devices Market Segment Analysis:

Transcatheter Mitral Valve Repair Devices Market by Product (Mechanical Valve and Bioprosthetic Tissue Valve), Indication (Mitral Valve Regurgitation, Mitral Valve Stenosis, and Others), End-User (Hospitals & Clinics, Ambulatory Surgical Centers, and Others), and Geography (North America, Europe, Asia-Pacific, and Rest of the World)

In the product segment of the transcatheter mitral valve repair devices market, the bioprosthetic tissue valve category is expected to amass significant revenue share in the year 2023. This can be ascribed to the advantages offered by the segment and the increasing prevalence of mitral valve regurgitation cases.

Bioprosthetic valves commonly used in clinical practice are called heterografts, which are usually stented or stentless porcine or bovine tissue valves. The bioprosthetic tissue valve category has higher efficacy as compared to the mechanical valve. The main advantage of bioprosthetic valves is that they do not require lifelong warfarin therapy, due to their lower thrombotic risk compared with mechanical valves.

Also, patients with bioprosthetic valves have a significantly decreased risk of bleeding.

Further, the increasing prevalence of heart valve diseases will increase the demand for bioprosthetic tissue valve devices. For instance, according to the Centers for Disease Control and Prevention (CDC) (2019), it was reported that in 2019, about 2.5% of the US population had valvular heart disease, being more common among the older population. Thus, the growing prevalence of valvular heart disease is expected to increase the demand for bioprosthetic tissue valve devices, thereby increasing the overall market growth.

Further, the increasing product launches and approvals and other strategic activities will in turn propel the demand for bioprosthetic tissue valve devices. For instance, in September 2021, Abbott received US FDA approval for Epic Plus and Epic Plus Supra Stented Tissue Valves to improve therapy options for people suffering from aortic or mitral valve disease. Epic Plus, a bioprosthetic valve, do not require long-term use of blood-thinner medication, making them the recommended option for people, especially aged over 70 years who are at risk of taking blood thinners.

Therefore, the advantages offered by bioprosthetic tissue valve devices along with the rising product launches are predicted to contribute to the increasing demand for this category, thereby driving the growth of the overall transcatheter mitral valve repair devices market during the forecast period.

North America is expected to dominate the overall Transcatheter Mitral Valve Repair Devices Market:

Among all the regions, North America is estimated to account for the largest share of the transcatheter mitral valve repair devices market in the year 2023. Owing to the factors such as the rising prevalence of heart valve diseases such as mitral valve stenosis, mitral valve prolapses, and mitral valve regurgitation. Apart from this, rising incidences of cardiovascular diseases such as strokes, and coronary artery diseases, among others, the rising burden of elderly patients prone to cardiovascular diseases, rising product approvals and launches, and escalating technological advancements are driving the North America transcatheter mitral valve repair devices market and is expected to witness positive growth.

According to the Canadian Cardiovascular Society (2023), it was reported that in 2022, 2.5% of the population had heart valve diseases, which is increasing significantly after the age of 65, reaching up to 13% after the age of 75. It was also estimated by the same source that in 2040, Canada will have an estimated 1.5 million people over 65 years with heart valve disease (HVD).

According to CDC (2019), it was reported that each year, about 805,000 people in the United States had a heart attack. Also, according to American Heart Association (2023), 20% of older Americans suffer from aortic stenosis, a common valve disease, each year.

Therefore, in such cases, transcatheter mitral valve repair device systems prove to be beneficial for the treatment of large patient pools suffering from heart valve diseases and other cardiovascular diseases, hence driving the demand and overall regional market of transcatheter mitral repair devices during the forecast period (2024-2030).

Coupled with the factors mentioned above, the increasing planned activities by the key players will also drive the market of transcatheter mitral valve repair devices. For instance, in September 2022, Edwards Lifesciences received FDA approval for its Pascal Precision system. The device used minimally invasive surgery to repair the mitral valve in patients with degenerative mitral regurgitation, a condition where the valve between heart chambers does not close completely, allowing blood to leak back through. Thus, such strategic steps help to increase the demand for transcatheter mitral valve repair devices, thereby driving the North America transcatheter mitral valve repair devices market forward during the forecast period.

Transcatheter Mitral Valve Repair Devices Market Key Players:

Some of the key market players operating in the transcatheter mitral valve repair devices market include Abbott, Edwards Lifesciences Corporation., Shockwave Medical, Inc., LivaNova PLC, NeoChord, Inc., Coramaze Technologies, CryoLife, Inc., Auto Tissue Berlin GmbH., Medtronic, Boston Scientific Corporation, JenaValve Technology, Inc., and others.

Recent Developmental Activities in the Transcatheter Mitral Valve Repair Devices Market:

In January 2023, Shockwave Medical, Inc., acquired Neovasc Inc., a company focused on the minimally invasive treatment of refractory angina, which is a chronic condition wherein a patient suffers chest pain that cannot be controlled by conventional therapies.

In January 2020, Abbott received CE Mark for its Tendyne Transcatheter Mitral Valve Implantation (TMVI) system for the treatment of mitral regurgitation (MR) in patients requiring a heart valve replacement and provides a safer option for candidates not willing to opt for open-heart surgery or transcatheter mitral valve repair.

Key Takeaways from the Transcatheter Mitral Valve Repair Devices Market Report Study

Market size analysis for current transcatheter mitral valve repair devices market size (2023), and market forecast for 5 years (2024-2030)

The effect of the COVID-19 pandemic on this market is significant. To capture and analyze suitable indicators, our experts are closely watching the transcatheter mitral valve repair devices market.

Top key product/services/technology developments, mergers, acquisitions, partnerships, and joint ventures happened for the last 3 years

Key companies dominating the global transcatheter mitral valve repair devices market.

Various opportunities available for the other competitor in the transcatheter mitral valve repair devices market space.

What are the top-performing segments in 2023? How these segments will perform in 2030.

Which are the top-performing regions and countries in the current transcatheter mitral valve repair devices market scenario?

Which are the regions and countries where companies should have concentrated on opportunities for transcatheter mitral valve repair devices market growth in the coming future?

Target Audience who can be benefited from this Transcatheter Mitral Valve Repair Devices Market Report Study

Transcatheter mitral valve repair devices products providers

Research organizations and consulting companies

Transcatheter mitral valve repair devices-related organizations, associations, forums, and other alliances

Government and corporate offices

Start-up companies, venture capitalists, and private equity firms

Distributors and Traders dealing in transcatheter mitral valve repair devices

Various End-users who want to know more about the transcatheter mitral valve repair devices market and the latest technological developments in the transcatheter mitral valve repair devices market.

Frequently Asked Questions for the Transcatheter Mitral Valve Repair Devices Market:

1. What are transcatheter mitral valve repair devices?

Transcatheter mitral valve repair devices are cardiac surgical devices that are used to treat heart valve diseases such as regurgitation, stenosis, and prolapse. Transcatheter mitral valve treatment is a minimally invasive procedure to replace a mitral valve that is not working properly.

2. What is the market for global transcatheter mitral valve repair devices?

The global transcatheter mitral valve repair devices market was valued at USD 1,197.06 million in 2023, growing at a CAGR of 14.95% during the forecast period from 2024 to 2030 to reach USD 2,756.71 million by 2030.

3. What are the drivers for the global transcatheter mitral valve repair devices market?

The demand for transcatheter mitral valve repair devices is primarily being heightened by the increasing prevalence of heart valve diseases, increasing prevalence of coronary artery disease, myocardial infarction, congestive heart failures, angina pectoris, and others. In addition, rising awareness and demand for minimally invasive devices, the increasing novel product launches and approvals, and innovation in product development thereby contribute to the overall growth of the transcatheter mitral valve repair devices market during the forecast period from 2024-2030.

4. Who are the key players operating in the global transcatheter mitral valve repair devices market?

Some of the key market players operating in the transcatheter mitral valve repair devices market include Abbott, Edwards Lifesciences Corporation., Shockwave Medical, Inc., LivaNova PLC, NeoChord, Inc., Coramaze Technologies, CryoLife, Inc., Auto Tissue Berlin GmbH., Medtronic, Boston Scientific Corporation, JenaValve Technology, Inc., and others.

5. Which region has the highest share in the transcatheter mitral valve repair devices market?

North America is expected to dominate the overall transcatheter mitral valve repair devices market during the forecast period from 2024-2030. Factors such as the rising prevalence of heart valve diseases, the increasing geriatric population prone to cardiovascular diseases, the rising number of risk factors, collaborations, acquisitions, partnerships among key market players in the market, and other factors are expected to drive the growth of the North American transcatheter mitral valve repair devices market.

Table of Contents

1.Transcatheter Mitral Valve Repair Devices Market Report Introduction

2. Transcatheter Mitral Valve Repair Devices Market Executive Summary

  • 2.1. Scope of the Study
  • 2.2. Market at Glance
  • 2.3. Competitive Assessment

3. Regulatory Analysis

  • 3.1. The United States
  • 3.2. Europe
  • 3.3. Japan
  • 3.4. China

4. Transcatheter Mitral Valve Repair Devices Market Key Factors Analysis

  • 4.1. Transcatheter Mitral Valve Repair Devices Market Drivers
    • 4.1.1. Rising prevalence of heart valve diseases
    • 4.1.2. Increasing preference for minimally invasive surgeries
  • 4.2. Transcatheter Mitral Valve Repair Devices Market Restraints and Challenges
    • 4.2.1. Risks of post-operational complications
  • 4.3. Transcatheter Mitral Valve Repair Devices Market Opportunities
    • 4.3.1. Presence of a robust number of repair devices in the pipeline

5. Transcatheter Mitral Valve Repair Devices Market Porter's Five Forces Analysis

  • 5.1. Bargaining Power of Suppliers
  • 5.2. Bargaining Power of Consumers
  • 5.3. Threat of New Entrants
  • 5.4. Threat of Substitutes
  • 5.5. Competitive Rivalry

6. Transcatheter Mitral Valve Repair Devices Market Layout

  • 6.1. By Type
    • 6.1.1. Mechanical Valve
    • 6.1.2. Bioprosthetic Tissue (Biological) Valve
  • 6.2. By Indication
    • 6.2.1. Mitral Valve Regurgitation
    • 6.2.2. Mitral Valve Stenosis
    • 6.2.3. Others
  • 6.3. By End-User
    • 6.3.1. Hospitals & Clinics
    • 6.3.2. Ambulatory Surgical Centers
    • 6.3.3. Others
  • 6.4. By Geography
    • 6.4.1. North America
      • 6.4.1.1. United States Transcatheter Mitral Valve Repair Devices Market Size in USD million (2021-2030)
      • 6.4.1.2. Canada Transcatheter Mitral Valve Repair Devices Market Size in USD million (2021-2030)
      • 6.4.1.3. Mexico Transcatheter Mitral Valve Repair Devices Market Size in USD million (2021-2030)
    • 6.4.2. Europe
      • 6.4.2.1. France Transcatheter Mitral Valve Repair Devices Market Size in USD million (2021-2030)
      • 6.4.2.2. Germany Transcatheter Mitral Valve Repair Devices Market Size in USD million (2021-2030)
      • 6.4.2.3. United Kingdom Transcatheter Mitral Valve Repair Devices Market Size in USD million (2021-2030)
      • 6.4.2.4. Italy Transcatheter Mitral Valve Repair Devices Market Size in USD million (2021-2030)
      • 6.4.2.5. Spain Transcatheter Mitral Valve Repair Devices Market Size in USD million (2021-2030)
      • 6.4.2.6. Rest of Europe Transcatheter Mitral Valve Repair Devices Market Size in USD million (2021-2030)
    • 6.4.3. Asia-Pacific
      • 6.4.3.1 China Transcatheter Mitral Valve Repair Devices Market Size in USD million (2021-2030)
      • 6.4.3.2. Japan Transcatheter Mitral Valve Repair Devices Market Size in USD million (2021-2030)
      • 6.4.3.3. India Transcatheter Mitral Valve Repair Devices Market Size in USD million (2021-2030)
      • 6.4.3.4. Australia Transcatheter Mitral Valve Repair Devices Market Size in USD million (2021-2030)
      • 6.4.3.5. South Korea Transcatheter Mitral Valve Repair Devices Market Size in USD million (2021-2030)
      • 6.4.3.6. Rest of Asia-Pacific Transcatheter Mitral Valve Repair Devices Market Size in USD million (2021-2030)
    • 6.4.4. Rest of the World (RoW)
      • 6.4.4.1. Middle East Transcatheter Mitral Valve Repair Devices Market Size in USD million (2021-2030)
      • 6.4.4.2. Africa Transcatheter Mitral Valve Repair Devices Market Size in USD million (2021-2030)
      • 6.4.4.3. South America Transcatheter Mitral Valve Repair Devices Market Size in USD million (2021-2030)

7. Transcatheter Mitral Valve Repair Devices Market Company and Product Profiles

  • 7.1. Abbott
    • 7.1.1. Company Overview
    • 7.1.2. Company Snapshot
    • 7.1.3. Financial Overview
    • 7.1.4. Product Listing
    • 7.1.5. Entropy
  • 7.2. Edwards Lifesciences Corporation.
    • 7.2.1. Company Overview
    • 7.2.2. Company Snapshot
    • 7.2.3. Financial Overview
    • 7.2.4. Product Listing
    • 7.2.5. Entropy
  • 7.3. Shockwave Medical, Inc.
    • 7.3.1. Company Overview
    • 7.3.2. Company Snapshot
    • 7.3.3. Financial Overview
    • 7.3.4. Product Listing
    • 7.3.5. Entropy
  • 7.4. LivaNova PLC
    • 7.4.1. Company Overview
    • 7.4.2. Company Snapshot
    • 7.4.3. Financial Overview
    • 7.4.4. Product Listing
    • 7.4.5. Entropy
  • 7.5. NeoChord, Inc.
    • 7.5.1. Company Overview
    • 7.5.2. Company Snapshot
    • 7.5.3. Financial Overview
    • 7.5.4. Product Listing
    • 7.5.5. Entropy
  • 7.6. Coramaze Technologies
    • 7.6.1. Company Overview
    • 7.6.2. Company Snapshot
    • 7.6.3. Financial Overview
    • 7.6.4. Product Listing
    • 7.6.5. Entropy
  • 7.7. CryoLife, Inc.
    • 7.7.1. Company Overview
    • 7.7.2. Company Snapshot
    • 7.7.3. Financial Overview
    • 7.7.4. Product Listing
    • 7.7.5. Entropy
  • 7.8. Auto Tissue Berlin GmbH.
    • 7.8.1. Company Overview
    • 7.8.2. Company Snapshot
    • 7.8.3. Financial Overview
    • 7.8.4. Product Listing
    • 7.8.5. Entropy
  • 7.9. Medtronic
    • 7.9.1. Company Overview
    • 7.9.2. Company Snapshot
    • 7.9.3. Financial Overview
    • 7.9.4. Product Listing
    • 7.9.5. Entropy
  • 7.10. Boston Scientific Corporation
    • 7.10.1. Company Overview
    • 7.10.2. Company Snapshot
    • 7.10.3. Financial Overview
    • 7.10.4. Product Listing
    • 7.10.5. Entropy
  • 7.11. JenaValve Technology, Inc
    • 7.11.1. Company Overview
    • 7.11.2. Company Snapshot
    • 7.11.3. Financial Overview
    • 7.11.4. Product Listing
    • 7.11.5. Entropy

8. KOL Views

9. Project Approach

10. About DelveInsight

11. Disclaimer & Contact Us